How to File a UK SCPN (Cosmetic Product Notification) for a Korean ODM K-Beauty Brand: A Step-by-Step Protocol for Indie Founders (2026)
By the ALTA MEET editorial team | K-beauty ODM consulting
If you are an indie K-beauty founder bringing a Korean ODM-manufactured product into the United Kingdom in 2026, the single piece of paperwork that decides whether you can legally place your product on a Boots shelf, a Cult Beauty grid, or a Sephora UK endcap is the UK Submit Cosmetic Product Notification, known by its OPSS acronym SCPN. The SCPN is not a customs filing. It is not a trademark. It is not an HMRC matter. It is the pre-market notification that tells the UK Office for Product Safety and Standards (OPSS) the formula, the responsible person, the intended use, and the label of every cosmetic SKU you intend to sell in Great Britain. No notification, no legal sale.
Founders who came up under the EU CPNP regime often assume the UK SCPN is "basically the same form, different login." It is not. Post-Brexit the UK has built its own portal, its own Responsible Person residency requirement, and from 2026 onward its own ingredient restriction lists that diverge from the EU's. A Korean ODM-made product approved for sale in Paris cannot be legally placed on a UK retailer's shelf until a UK-resident Responsible Person has filed the SCPN, holds the Product Information File on UK soil, and has the new UK fragrance allergen labels printed on the carton.
This guide walks the protocol end to end. Each step is sized for an indie founder who is filing for the first time on a 1,000-unit Korean ODM production run, with realistic 2026 timelines, 2026 GBP cost ranges from ALTA MEET's recent UK indie briefs, and the practical mistakes that make founders pay twice.
Why This Matters Now (2026 UK Compliance Snapshot)
Three regulatory shifts make 2026 the year UK SCPN protocol literacy is no longer optional for indie K-beauty founders.
First, from 1 January 2026 the UK cosmetic labeling regime requires declaration of an expanded list of fragrance allergens on the ingredient label, up from the legacy 26-substance list to roughly 80 substances, aligning the UK label requirement with the EU's expanded allergen list adopted in Regulation (EU) 2023/1545. A Korean ODM fragrance bouquet that previously triggered three allergens may now trigger eight or nine, and the additional allergens must be visible on the printed carton or unit. If your cartons were printed for the legacy 26-allergen list, they must be re-spec'd before the UK SCPN can be filed against the final-label artwork. The OPSS does not police your carton typography; the trade enforcement officers at your retail accounts will.
Second, on 15 August 2026 the UK Statutory Instrument SI 2026/23 will bring a new wave of Carcinogenic, Mutagenic and Reprotoxic (CMR) substance prohibitions and restrictions into UK Cosmetics Regulation. Korean ODMs tend to have already substituted away from EU/UK Annex II prohibited substances by default because Korean MFDS standards have tracked the EU list closely for over a decade, but the 2026 CMR additions are new and your Korean ODM may legitimately not yet know that ingredient X in the formula they have been quoting you on is now prohibited in Great Britain. You catch this at the SCPN-prep stage, not after the carton is on the truck.
Third, the UK-Republic of Korea Free Trade Agreement remains in force, with the vast majority of Korean-origin tariff lines duty-free under a Statement on Origin, and the UK indie K-beauty retail buyer is increasingly literate enough to ask the founder which CPSR assessor signed the safety report. The compliance bar in the UK indie K-beauty channel in 2026 is no longer "you have a brand"; it is "you can prove you have a UK RP, a UK-signed CPSR, a complete PIF, and an SCPN reference number per SKU on demand."
If you have already read our K-Beauty Manufacturing Cost in GBP guide for the cost side of UK entry, this post is the regulatory companion: how to actually file the notification without paying twice.
Prerequisites Before You Start (Don't Skip)
Before you log into the gov.uk SCPN portal, six things must be true. Founders who skip this list spend two months bouncing between the assessor, the Korean ODM, and the printer.
You have a finalised Korean ODM bulk formula with locked INCI percentages. "Approximately 2 to 3 percent niacinamide" is not a formula; it is a marketing line. The CPSR cannot be written against a range. The Korean ODM must give you a single number per ingredient, the regulatory dossier-ready INCI list in compliant nomenclature, and a Certificate of Analysis (CoA) for the production batch the SCPN will reference.
You have packaging artwork files at print resolution with the full ingredient list, country of origin, batch code position, RP name and UK address, and net content. The SCPN portal will ask for label images. If you upload the front-of-carton only, the assessor cannot sign off, and the OPSS expects the back-of-carton with the legally required disclosures.
You have decided on your UK Responsible Person and have a signed agreement. The UK RP is the person or company legally responsible for the product in Great Britain; their name and UK address appear on the carton; they hold the PIF on UK soil; they answer to OPSS inspections. Indie founders without UK presence almost always contract a third-party RP service. Pricing in 2026 sits in the £500 to £2,000 per year range for indie SKU portfolios of 4 to 6 products.
You have commissioned (or scoped) a UK CPSR. The Cosmetic Product Safety Report is the mandatory technical safety dossier. It must be signed by a UK-qualified safety assessor (toxicologist, pharmacist, or equivalent with the required scientific qualifications under retained Regulation (EC) 1223/2009 Annex I requirements). Indie 2026 pricing typically runs £180 to £300 for the first variant of a formula and £50 to £150 per additional variant in the same product family.
You have a GOV.UK One Login account in the name of your business or your contracted UK RP. The SCPN portal at submit.cosmetic-product-notifications.service.gov.uk requires GOV.UK One Login; new founders often discover only at filing time that the login must be in the RP's name, not the founder's personal name.
You have decided which entity is going to invoice your UK retailers. The SCPN names a single Responsible Person, but the entity invoicing Boots can be your US LLC, your UK Limited company, or a UK distributor. The choice cascades into HMRC, VAT registration above the £90,000 threshold, and CIF base for landed cost. Do not file the SCPN before you have decided which company is the contracting entity, because changing the RP later means re-filing.
Step 1: Designate Your UK Responsible Person
The Responsible Person is the legal anchor of the UK Cosmetics Regulation. For a Korean ODM K-beauty indie brand without a UK office, this almost always means contracting a UK-based RP service. The contract gives you four things: a UK address that will appear on the carton, an email and phone for OPSS inquiries, a holder for the PIF on UK soil, and a designated SCPN portal filer.
Practical points for indie founders. The UK RP must be established in the UK; an EU RP (for example a Paris-based service that handles your CPNP) cannot cover Great Britain (Northern Ireland follows EU rules separately, so an EU RP can cover NI but not England, Scotland, or Wales). The same UK RP should ideally hold all your SKUs across your indie K-beauty line, because the RP audit trail and PIF storage are far cleaner under one custodian than split across two.
Budget. Recurring UK RP service for an indie portfolio of 4 to 6 SKUs in 2026 typically runs £500 to £2,000 per year depending on whether the package includes CPSR storage, label artwork pre-checks, and SCPN re-filings on reformulation. Treat the £1,000 mid-range as a planning number until you have specific quotes.
Timeline. Most reputable UK RP services can onboard a Korean ODM-supplied indie brand in 5 to 10 working days, contingent on receipt of the formula, INCI list, draft artwork, and a signed RP agreement. The RP onboarding is the gate to Steps 2 to 6; do not start commissioning the CPSR until the RP is engaged.
Step 2: Collect Korean ODM Regulatory Documentation
The CPSR assessor will not start work without a regulatory dossier from the Korean ODM. The dossier is standard at any reputable Korean ODM that has shipped to the EU before, but indie founders making a first cross-border briefcase often do not know to request it explicitly. Ask in writing for the following, in English, with the ODM's stamp.
Quantitative formula with locked percentages per ingredient. Marketing names are not enough; you need the regulatory INCI name (e.g. Niacinamide, not Vitamin B3 Form), the percentage to two decimal places, and any sub-ingredients within a complex blend.
Specification sheet for each raw material, with batch traceability back to the supplier of record. The assessor's toxicological profile relies on the impurity envelope, not just the active.
Microbiological test results per ISO 17516:2014 (microbial limits, with 1,000 CFU/g for leave-on standard products and 100 CFU/g for eye-area, pediatric, or mucosal-contact products) and preservative efficacy per ISO 11930.
Stability data per ICH Q1A(R2)-style protocols (accelerated 40°C ± 2°C / 75% RH ± 5% RH for at least 6 months, real-time 25°C ± 2°C / 60% RH ± 5% RH ongoing). Indie founders frequently sign off on samples without stability data and pay for it months later when the CPSR assessor refuses to write the report.
GMP certification. Reputable Korean ODMs hold ISO 22716 certification (cosmetic Good Manufacturing Practice); ask for the certificate and the audit date.
Batch CoA for the production run. The SCPN is filed against the production formula, so the CoA confirms that the bulk you are notifying matches the formula in the CPSR.
A small but real point: ask the Korean ODM for the documents in English. Many indie founders accept Korean-only Certificates of Analysis and discover at CPSR commissioning time that the assessor will charge extra for translation, or refuse to start.
If you need help structuring the documentation request, our how-to-brief-a-Korean-ODM template covers the upstream brief; the regulatory documentation request can be appended as a final section.
Step 3: Commission the UK CPSR
The Cosmetic Product Safety Report is the document that turns "I have a formula" into "I have a legally salable product in Great Britain." Under the UK Cosmetics Regulation it is mandatory before market placement, must be signed by a qualified UK-based safety assessor, and forms the technical core of the PIF.
Scope. A CPSR is per formula, not per SKU. If you have one serum sold in three sizes (15 ml, 30 ml, 50 ml), one CPSR covers the formula and the three SCPN filings reference it. If you have one serum and one cream, you need two CPSRs.
Cost. Indie UK CPSR pricing in 2026 sits in the £180 to £300 range for the first variant of a product family and £50 to £150 per additional variant. A four-SKU indie K-beauty line (cleanser, serum, moisturiser, sunscreen) with no shared base formulations should budget £800 to £1,400 for the CPSR set.
Timeline. With a complete regulatory dossier from the Korean ODM, a UK assessor will typically deliver the CPSR in 10 to 20 working days. If the dossier is incomplete, expect 4 to 6 weeks of back-and-forth.
Sunscreen footnote. UK sunscreens are cosmetics, not OTC drugs, but their UV filter approval list differs from both the US and Korea. Korean ODMs commonly formulate with newer UV filters from the Korean 30+ approved-filter list that are not on the UK Annex VI permitted list. Confirm UK Annex VI compatibility at CPSR commissioning, before you commit to a Korean ODM's preferred SPF base.
Step 4: Build the Product Information File (PIF)
The PIF is the dossier the UK RP must hold available for OPSS inspection on UK soil for 10 years after the last batch is placed on the market. It is not filed with OPSS; it is held by the RP and produced on demand. The SCPN is essentially the OPSS-facing notification that the PIF exists.
PIF contents. Description of the cosmetic product. CPSR. Manufacturing method statement (typically a one-page declaration from the Korean ODM that the product is manufactured in accordance with Good Manufacturing Practice ISO 22716). Evidence of any claimed effect (clinical or in vitro substantiation for marketing claims like "24-hour hydration" or "reduces appearance of fine lines"). Data on animal testing (post-2013 EU ban inherited via retained law; indie K-beauty brands usually file a negative-declaration statement from the Korean ODM confirming no animal testing was performed on the finished product or its ingredients for cosmetic purposes).
Practical pattern. Most UK RP services will assemble the PIF on your behalf once you supply the inputs. The assembly is rarely a cost line item by itself but is bundled into the RP annual fee. Confirm that the PIF will be held in the UK in either physical or electronically accessible form at the RP's UK address.
Substantiation traps for indie K-beauty marketing. Korean ODMs often supply consumer-perception study reports that read more as marketing than as claim substantiation. If you intend to make objective claims ("clinically proven to reduce hyperpigmentation"), you need an instrumental study (chromameter, mexameter, image analysis) with a trained dermatology investigator, not a satisfaction survey. The PIF substantiation line is the one OPSS will inspect first when a competitor flags your claim.
Step 5: Set Up the gov.uk SCPN Account and One Login
The SCPN portal lives at submit.cosmetic-product-notifications.service.gov.uk and uses GOV.UK One Login as the authentication layer. Two practical points.
The One Login should be in the name of your UK RP (or a delegated user under the RP's organization), not your personal name as the founder. The portal records who notified each product. If the One Login is in your personal name and you later switch RPs, the audit trail becomes muddled and you may have to re-notify.
The portal supports both single-product notifications and bulk notifications (for example, a multi-variant lipstick range). For an indie K-beauty founder shipping 4 to 6 distinct SKUs, single-product notifications per SKU are simpler and faster than bulk format.
If your RP is contracted to file on your behalf (which is the norm), you provide the inputs and the RP performs the actual portal submission. Treat this step as the RP's job, not yours; your job is to verify before submission that the inputs are correct.
I'm Liz, I run ALTA MEET from Manhattan, NYC. The UK SCPN protocol is where most indie K-beauty founders trip over their first cross-border filing: they think it is a clerical task and discover it is actually a documentation chain that runs all the way back to the Korean ODM's Certificate of Analysis. We help founders sequence the documents in the right order so the CPSR assessor and the UK RP never get blocked. If you want a quick gut-check on whether your Korean ODM brief is UK-SCPN-ready, grab 15 minutes free with me.
Step 6: File the SCPN per Product
The actual SCPN filing per SKU asks for a defined set of inputs. Founders who file in 10 minutes per SKU have prepared the inputs in advance; founders who file in 4 hours per SKU are searching for documents mid-form.
The minimum SCPN input set per product is the product name, the product category (one of the OPSS-defined cosmetic categories, e.g., "skin care products"), the intended use, the name and address of the Responsible Person, the country of origin, the SCPN frame formulation reference, the level of CMR substances (Categories 1A, 1B, and 2) if any are present, the level of nanomaterials if any are present, the presence of substances in the form of nanomaterials, the original labels (front and back of carton, plus the unit/inner packaging), the photograph of the product where reasonably required, and a 2D photo or label image where the carton is the original packaging.
A common indie K-beauty trap. The "frame formulation" reference is the standardised classification of the broad product type (e.g., emulsion vs. anhydrous oil, with broad ingredient buckets). It is not the full quantitative formula. The exact percentages stay in the PIF, not the SCPN portal. Founders sometimes panic that they have to expose their formula publicly through the SCPN; they do not. The quantitative formula stays with the RP and is only shown to OPSS on inspection.
Confirmation. After submission the portal returns an SCPN reference number. Save this. Retailers will ask for it during compliance onboarding. The reference also evidences the date of notification, which matters because the SCPN must be filed before the product is "placed on the market" (defined as the moment of first making the product available for distribution or use on the GB market, not the moment of consumer sale).
Step 7: Post-Notification Compliance (Labels, Updates, Withdrawals)
Filing the SCPN is not the end of the regulatory work; it is the start of the maintenance cycle.
Labeling check. Once the SCPN reference is in hand, the printed carton must match the SCPN exactly. The RP's UK address must be visible on the carton (this is the UK RP, not the Korean ODM and not your US LLC). The 2026 fragrance allergen list must be on the ingredient label as applicable. Net content, batch code position, country of origin, and minimum durability or PAO must be present. If your printed cartons predate the 2026 allergen list, schedule a relabel before market placement.
Reformulation triggers. Any change to the quantitative formula that affects safety triggers a CPSR update and a SCPN re-filing. Changing the fragrance bouquet, the preservative system, or the active concentrations is non-trivial. Switching the country of origin is non-trivial. Cosmetic changes (re-naming the SKU, redesigning the carton without changing the ingredient list) are notifiable but lighter-weight.
Adverse event reporting. Under retained EU 1223/2009 Article 23, the RP must keep records of "serious undesirable effects" and report them to OPSS when they meet the regulatory threshold. The indie founder's job is to forward consumer complaints to the RP promptly. Most RPs run a quarterly review of inbound complaints; weekly review is good practice if your product is selling at retail volume.
Product Information File maintenance. As the product evolves (new batches, new artwork, new clinical claims), the PIF must reflect the current version. The RP holds the PIF, but the inputs are yours. Treat PIF updates as a quarterly housekeeping line item.
Withdrawal protocol. If you discontinue a SKU, the SCPN notification stays in the OPSS record (it is a notification, not a license, and there is no separate withdrawal step in the portal in 2026), but you should update the RP and stop placing the product on the market. The PIF retention obligation continues for 10 years from the last batch placed.
Common Indie K-Beauty Mistakes (And What They Cost)
Five mistakes appear in the indie K-beauty UK SCPN protocol again and again. Each costs three to twelve weeks of delay and £500 to £4,000 of avoidable spend.
Mistake one. Printing UK cartons before the CPSR is signed. Founders excited to receive their first Korean ODM samples ship the carton artwork to the printer in parallel with commissioning the CPSR. The CPSR assessor returns the report with a labeling note ("PAO must be 12M not 24M based on the preservative system"), and 1,000 cartons must be reprinted at £400 to £900. Hold the printer's go-ahead until the CPSR is signed.
Mistake two. Filing the SCPN against the wrong product category. The OPSS category list determines the regulatory framework; a "facial cleanser" filed as "shower/bath products" can trigger an unnecessary preservative efficacy investigation at the assessor stage. The Korean ODM will know the right category; ask them in writing.
Mistake three. Failing to specify the Korean ODM as the manufacturer in the regulatory documentation. Some Korean ODMs supply formulas that they sub-contract to a sister facility, and the regulatory documentation lists the sub-contractor, not the ODM brand the founder thinks they are working with. The SCPN names the manufacturer; mismatched documentation triggers a clarification round with the assessor and, in worst cases, a CPSR rewrite.
Mistake four. Treating the EU CPNP and the UK SCPN as one filing. They are now two separate notifications under two separate regimes, with different Responsible Persons. If you have an EU CPNP already from a French RP and assume it covers the UK, your product is not legally on the UK market. Our EU CPNP step-by-step guide covers the EU side; the UK SCPN is a separate filing.
Mistake five. Underestimating the UK RP recurring cost. Founders price the CPSR (a one-time cost per formula) and forget that the UK RP is a recurring £500 to £2,000 per year cost. Build the annual RP fee into your indie K-beauty unit economics before you commit to a 1,000-unit Korean ODM production run.
Reading the SCPN Filing Inside a 1,000-MOQ Indie K-Beauty UK Launch (Cost Map, GBP)
Here is a realistic cost stack for a first-time UK SCPN filing on a 1,000-unit per-SKU Korean ODM production run, four-SKU indie K-beauty line (cleanser, serum, moisturiser, mineral SPF), 2026 GBP.
Year-one compliance cost stack.
UK Responsible Person service, indie tier covering 4 SKUs: £800 to £1,500 in year one.
UK CPSR set across 4 distinct formulas: 4 × £180 to £300 for the lead variant of each = £720 to £1,200. If two SKUs share a base (e.g., night cream and day cream share the emulsion base), one is the lead and the other is the variant, saving roughly £130 to £250.
Carton relabel for 2026 fragrance allergen list (if the Korean ODM artwork predates 2026): £400 to £900 per SKU, depending on volume tier. Most indie K-beauty UK launches in 2026 should print fresh cartons against the new list directly.
GOV.UK One Login and SCPN filing per SKU: portal access is free; the RP's labor for filing is bundled into the annual RP fee.
Adverse event reporting infrastructure setup: typically bundled into the RP fee, occasionally a £200 to £500 one-time line item depending on the provider.
PIF assembly and storage: bundled into the RP fee in the typical indie tier.
Substantiation studies for any objective claims: if you plan to make instrumental claims, a small panel chromameter study runs £2,500 to £6,000 per claim; many indie K-beauty brands wait until year two to add instrumental claims and launch with descriptive claims first.
Year-one all-in compliance cost for a 4-SKU indie K-beauty UK launch typically sits in the £2,500 to £4,500 range, exclusive of substantiation studies. On a 1,000-unit per-SKU run (4,000 units total), this adds £0.60 to £1.10 per unit to the landed cost stack. Plan for the higher end of the range until you have firm quotes.
This sits on top of the manufacturing and logistics cost stack documented in our K-Beauty Manufacturing Cost in GBP guide, which covers the per-unit Korean ODM bulk, packaging, freight, duty, and VAT recovery math.
Realistic Timeline (Production Approval to First UK Retail PO)
For an indie K-beauty founder with a finalised Korean ODM formula, the typical UK SCPN-ready timeline from final formula approval to a legally-shippable first carton runs 8 to 14 weeks.
Weeks 1 to 2: UK RP onboarding, Korean ODM regulatory dossier collection.
Weeks 3 to 6: CPSR commissioning and writing (10 to 20 working days with a complete dossier; longer if the Korean ODM is missing stability or microbiological documentation).
Weeks 5 to 7: Final carton artwork against the signed CPSR; printer go-ahead; print and ship cartons to Korean ODM for filling.
Weeks 6 to 8: PIF assembly by the UK RP.
Weeks 7 to 9: SCPN filing per SKU; reference numbers received.
Weeks 9 to 14: Korean ODM production run (varies by SKU and ODM lead time), shipping to UK 3PL, first cartons available for retail PO.
The SCPN itself is not the bottleneck once the prerequisites are in place. The CPSR is the long pole. Founders who pre-commission the CPSR while the Korean ODM is still in late-stage sample iteration can cut three weeks off the total timeline.
Key Takeaways
The UK SCPN is the gateway notification for Great Britain market placement of any Korean ODM K-beauty product. It is filed via gov.uk's SCPN portal at submit.cosmetic-product-notifications.service.gov.uk by a UK-resident Responsible Person, who also holds the Product Information File on UK soil.
A UK RP is required (an EU RP does not cover Great Britain). Budget £500 to £2,000 per year recurring for indie portfolios of 4 to 6 SKUs.
A UK CPSR signed by a qualified UK-based safety assessor is mandatory before SCPN filing. Budget £180 to £300 for the lead variant and £50 to £150 for each subsequent variant in the same family.
The 1 January 2026 expanded fragrance allergen labeling requirement (≈80 substances) is now active and likely requires fresh carton artwork against the new list for most Korean ODM-supplied indie brands.
The 15 August 2026 SI 2026/23 CMR substance prohibitions will require a formula review for any product launching in late 2026; confirm with the Korean ODM and the CPSR assessor that the formula remains compliant.
The most common indie K-beauty mistake is printing cartons before the CPSR is signed. Hold the printer until the assessor signs off.
A realistic UK SCPN-ready timeline from final formula approval to a shippable first carton runs 8 to 14 weeks. Year-one all-in compliance cost for a 4-SKU indie K-beauty UK launch typically sits in the £2,500 to £4,500 range, exclusive of substantiation studies, adding £0.60 to £1.10 per unit to landed cost on a 4,000-unit total run.
FAQ
Q1. Do I need a UK SCPN if I am only selling on a UK Shopify store, not on Boots or Cult Beauty? Yes. The "placing on the market" definition under retained Regulation (EC) 1223/2009 covers any first making available for distribution or use on the Great Britain market, including direct-to-consumer ecommerce. A UK SCPN per SKU is required before the first DTC order ships into England, Scotland, or Wales.
Q2. Does my Northern Ireland customer base require a separate notification? Northern Ireland continues to follow EU cosmetic rules under the Windsor Framework as of mid-2026. NI sales are covered by the EU CPNP notification, not the UK SCPN. If you sell in both GB and NI, you need both an SCPN (via UK RP) and a CPNP (via EU RP). The two RPs can be different entities; the two PIFs are separate.
Q3. Can the Korean ODM be the Responsible Person? No. The UK Cosmetics Regulation requires the RP to be established in the UK. A Korean ODM cannot be the RP. The founder's UK Limited company can be the RP if the founder has UK operations; otherwise contract a third-party UK RP service.
Q4. How long does the SCPN itself take to process at OPSS? The SCPN is a notification, not an approval. There is no OPSS review period. Once submitted through the portal and accepted, the reference number is generated on submission and the product can legally be placed on the GB market subject to the labeling, PIF, and other compliance steps being complete. The bottleneck is upstream of the SCPN (CPSR signing), not in the OPSS portal itself.
Q5. What happens if I sell on the GB market without an SCPN? You face fines and potential imprisonment. Specifically, current UK enforcement provides for fines and a prison term of up to 3 months for failure to notify, with unlimited fines available in England and Wales or up to £5,000 in Scotland and Northern Ireland. Retailers like Boots and Cult Beauty require SCPN reference numbers at compliance onboarding and will reject SKUs without them.
Q6. Does the SCPN expose my formula to competitors? No. The SCPN portal asks for the frame formulation reference (a broad classification), not the quantitative formula. The quantitative formula stays in the PIF, which is held by the UK RP on UK soil and is shown only to OPSS on regulatory request.
Q7. If my Korean ODM is ISO 22716 certified, do I still need a separate UK GMP statement? You typically need a one-page manufacturing method statement from the Korean ODM confirming production in accordance with ISO 22716. This sits in the PIF and is signed by the manufacturer. The ISO 22716 certificate itself is evidence; the statement formalises the declaration for the PIF.
Working With ALTA MEET
ALTA MEET is a boutique Korean ODM consultancy based in Manhattan, NYC, with hands-on Seoul-side oversight. We work with indie K-beauty founders launching in the US, the UK, the EU, and direct-to-consumer markets. Our practice covers Korean ODM selection, brief writing, sample evaluation, cost negotiation, MoCRA registration, EU CPNP filing, UK SCPN sequencing, and the cross-jurisdictional documentation chain that makes the difference between a launch that ships on time and a launch that pays twice.
If you are scoping a UK launch through a Korean ODM and want a second opinion on whether your formula, your timeline, and your retail commitments line up, book a free 15-min K-Beauty manufacturing gut-check with Liz. Fifteen minutes, two routing questions, no pitch.
Reviewed for accuracy by ALTA MEET's formulation consulting team.
